Jeffrey Albers – Biography
Last update: January 14, 2026Executive profile
Jeffrey was Chief Executive Officer at Blueprint Medicines, and Board Member at Kymera Therapeutics. Jeffrey Albers joined Spyre Therapeutics in 2023.
Jeffrey Albers is currentlyDirector at Spyre Therapeutics - View - Spyre Therapeutics org chart
Create your alert
to follow the career of Jeffrey Albers.
Education
Jeffrey Albers has a Master of Business Administration from Georgetown University McDonough School of Business.
They have also studied at Georgetown University McDonough School of Business :
Find more alumni from Georgetown University McDonough School of Business
More about Jeffrey Albers
Selected links
Do you need to know more about Jeffrey Albers? More results.
Participate
Social media
- Jeffrey Albers on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Jeffrey Albers
The colleagues of Jeffrey Albers
Company Colleagues
- At Spyre Therapeutics, Jeffrey Albers has 27 colleagues including Cameron Turtle (CEO & Director), Sandra Milligan (Director)…
Industry Colleagues
- In the Biotechnology industry, Jeffrey Albers has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Jeffrey Albers.
Get in Touch
Here are a few tips for establishing great contacts.
